Serum uric acid to serum creatinine ratio predicts neurological deterioration in branch atheromatous disease

Background and objectiveBranch atheromatous disease (BAD) makes patients prone to early neurological deterioration (END), resulting in poor prognosis. The aim of this study was to investigate the association between SUA/SCr and END in BAD stroke patients.MethodsWe conducted a retrospective study tha...

Full description

Bibliographic Details
Main Authors: Yinglin Liu, Honglei Wang, Ronghua Xu, Lanying He, Kun Wu, Yao Xu, Jian Wang, Fan Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2023.1098141/full
_version_ 1797946930085494784
author Yinglin Liu
Honglei Wang
Ronghua Xu
Lanying He
Kun Wu
Yao Xu
Jian Wang
Fan Xu
author_facet Yinglin Liu
Honglei Wang
Ronghua Xu
Lanying He
Kun Wu
Yao Xu
Jian Wang
Fan Xu
author_sort Yinglin Liu
collection DOAJ
description Background and objectiveBranch atheromatous disease (BAD) makes patients prone to early neurological deterioration (END), resulting in poor prognosis. The aim of this study was to investigate the association between SUA/SCr and END in BAD stroke patients.MethodsWe conducted a retrospective study that included 241 patients with BAD-stroke within 48 h of symptom onset. We divided the patients into the END group and the no END group. END was defined as an NIHSS score increase of more than 2 points within 1 week. SUA/SCr was calculated by the concentration of serum uric acid and creatine (serum uric acid/serum creatine) on admission. Univariate and multivariate analyses were used to identify independent predictors of END in BAD-stroke patients.ResultsEND was observed in 24.1% (58/241) of the patients in our study. Multiple logistic regression analyses showed that SUA/SCr (aOR, 0.716; 95% CI, 0.538–0.952; P = 0.022) and female sex (aOR, 0.469; 95% CI, 0.245–0.898; P = 0.022) were associated with END after adjusting for confounding factors. The predicted value of SUA/Scr for END was a sensitivity of 79.3%, a specificity of 44.8%, and an AUC of 0.609 (95% CI, 0.527–0.691, P < 0.05). The optimal cut-off value was 4.76.ConclusionSUA/SCr was negatively associated with the risk of END in BAD stroke patients.
first_indexed 2024-04-10T21:19:55Z
format Article
id doaj.art-ad8d3ccd70664e74929db7c805f0f5db
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-04-10T21:19:55Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-ad8d3ccd70664e74929db7c805f0f5db2023-01-20T07:22:29ZengFrontiers Media S.A.Frontiers in Neurology1664-22952023-01-011410.3389/fneur.2023.10981411098141Serum uric acid to serum creatinine ratio predicts neurological deterioration in branch atheromatous diseaseYinglin Liu0Honglei Wang1Ronghua Xu2Lanying He3Kun Wu4Yao Xu5Jian Wang6Fan Xu7Department of Neurology, Chengdu Second People's Hospital, Chengdu, Sichuan, ChinaDepartment of Neurology, Yibin Second People's Hospital, Yibin, Sichuan, ChinaDepartment of Neurology, Chengdu Second People's Hospital, Chengdu, Sichuan, ChinaDepartment of Neurology, Chengdu Second People's Hospital, Chengdu, Sichuan, ChinaDepartment of Laboratory, Yibin Sixth People's Hospital, Yibin, Sichuan, ChinaDepartment of Radiology, Pingshan County People's Hospital, Chengdu, Sichuan, ChinaDepartment of Neurology, Chengdu Second People's Hospital, Chengdu, Sichuan, ChinaDepartment of Public Health, School of Public Health, Chengdu Medical College, Chengdu, Sichuan, ChinaBackground and objectiveBranch atheromatous disease (BAD) makes patients prone to early neurological deterioration (END), resulting in poor prognosis. The aim of this study was to investigate the association between SUA/SCr and END in BAD stroke patients.MethodsWe conducted a retrospective study that included 241 patients with BAD-stroke within 48 h of symptom onset. We divided the patients into the END group and the no END group. END was defined as an NIHSS score increase of more than 2 points within 1 week. SUA/SCr was calculated by the concentration of serum uric acid and creatine (serum uric acid/serum creatine) on admission. Univariate and multivariate analyses were used to identify independent predictors of END in BAD-stroke patients.ResultsEND was observed in 24.1% (58/241) of the patients in our study. Multiple logistic regression analyses showed that SUA/SCr (aOR, 0.716; 95% CI, 0.538–0.952; P = 0.022) and female sex (aOR, 0.469; 95% CI, 0.245–0.898; P = 0.022) were associated with END after adjusting for confounding factors. The predicted value of SUA/Scr for END was a sensitivity of 79.3%, a specificity of 44.8%, and an AUC of 0.609 (95% CI, 0.527–0.691, P < 0.05). The optimal cut-off value was 4.76.ConclusionSUA/SCr was negatively associated with the risk of END in BAD stroke patients.https://www.frontiersin.org/articles/10.3389/fneur.2023.1098141/fullbranch atheromatous diseaseearly neurological deteriorationSUA/SCruric acidprognosis
spellingShingle Yinglin Liu
Honglei Wang
Ronghua Xu
Lanying He
Kun Wu
Yao Xu
Jian Wang
Fan Xu
Serum uric acid to serum creatinine ratio predicts neurological deterioration in branch atheromatous disease
Frontiers in Neurology
branch atheromatous disease
early neurological deterioration
SUA/SCr
uric acid
prognosis
title Serum uric acid to serum creatinine ratio predicts neurological deterioration in branch atheromatous disease
title_full Serum uric acid to serum creatinine ratio predicts neurological deterioration in branch atheromatous disease
title_fullStr Serum uric acid to serum creatinine ratio predicts neurological deterioration in branch atheromatous disease
title_full_unstemmed Serum uric acid to serum creatinine ratio predicts neurological deterioration in branch atheromatous disease
title_short Serum uric acid to serum creatinine ratio predicts neurological deterioration in branch atheromatous disease
title_sort serum uric acid to serum creatinine ratio predicts neurological deterioration in branch atheromatous disease
topic branch atheromatous disease
early neurological deterioration
SUA/SCr
uric acid
prognosis
url https://www.frontiersin.org/articles/10.3389/fneur.2023.1098141/full
work_keys_str_mv AT yinglinliu serumuricacidtoserumcreatinineratiopredictsneurologicaldeteriorationinbranchatheromatousdisease
AT hongleiwang serumuricacidtoserumcreatinineratiopredictsneurologicaldeteriorationinbranchatheromatousdisease
AT ronghuaxu serumuricacidtoserumcreatinineratiopredictsneurologicaldeteriorationinbranchatheromatousdisease
AT lanyinghe serumuricacidtoserumcreatinineratiopredictsneurologicaldeteriorationinbranchatheromatousdisease
AT kunwu serumuricacidtoserumcreatinineratiopredictsneurologicaldeteriorationinbranchatheromatousdisease
AT yaoxu serumuricacidtoserumcreatinineratiopredictsneurologicaldeteriorationinbranchatheromatousdisease
AT jianwang serumuricacidtoserumcreatinineratiopredictsneurologicaldeteriorationinbranchatheromatousdisease
AT fanxu serumuricacidtoserumcreatinineratiopredictsneurologicaldeteriorationinbranchatheromatousdisease